Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on MediCaps Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts MediCaps Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • MediCaps - Information Regarding E-Voting For 42Nd Annual General Meeting

    26 Aug 2025, 1:46PM Information under Regulation 44 of SEBI (LODR) Regulation, 2015 and Section 108 of Companies Act, 2013 regarding Voting through Electronic Mode for th
  • MediCaps - Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Reg

    26 Aug 2025, 1:37PM Intimation for Dispatch of Letter to those Shareholders whose E-Mail Addresses are not registered with company/Registrar & Transfer Agent/Depository P
  • MediCaps - Reg. 34 (1) Annual Report.

    26 Aug 2025, 12:36PM Submission of Annual Report for the Financial Year 2024-25 pursuant to Regulation 34 of SEBI (Listing Obligation and Disclosure Requirement) Regulatio
  • MediCaps - Submission Of Notice Of Convening 42Nd AGM Of The Company.

    26 Aug 2025, 12:29PM Submission of notice of 42nd AGM scheduled to be held on 18th September, 2025 at 12:30 P.M. (IST) through Video Conference (VC) / Other audio visual m
  • MediCaps - Submission Of Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30.06.2025

    5 Aug 2025, 5:14PM Submission of Unaudited standalone & Consolidated financial results for the quarter ended 30.06.2025
  • MediCaps - Announcement under Regulation 30 (LODR)-Change in Management

    5 Aug 2025, 4:59PM Re-Appointment of Mr. Dharmendra Solanki as a Independent Director for Second Term
  • MediCaps - Announcement under Regulation 30 (LODR)-Change in Management

    5 Aug 2025, 4:55PM Appointment of Secretarial Auditor of the Company
  • MediCaps - Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON TUESDAY, 05TH AUGUST, 2025 PURSUANT TO REGULATION 30 OF

    5 Aug 2025, 4:05PM Board of Directors at their meeting held on today i.e. Tuesday 05th August, 2025 has inter alia considered and approved the various business as mentio
  • MediCaps - Board Meeting Intimation for Board Meeting (Serial No. 02/2025-26) Of The Company, Scheduled To Be Held On Tuesday

    28 Jul 2025, 2:19PM Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and appro
  • MediCaps has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    12 Jul 2025, 7:02AM As of June 2025, 50.76% is owned by Indian Promoters and 49.23% by Public. <p align=justify> Top five Promoters holding highest number of shares of Me
  • MediCaps - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    4 Jul 2025, 2:51PM Certificate for compliance of regulation 74(5) of SEBI(DP) Regulation, 2018 for the quarter 30.06.2025
  • MediCaps - Intimation Of Receipts Of Work Completion Certificate

    16 Jun 2025, 7:33PM Intimation of work completion certificate of Medi-caps Business Park at Pithampur Dist -Dhar (M.P.)

Key fundamentals

Evaluate the intrinsic value of MediCaps Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 67.3439 66.4893 61.1075 61.288 60.969
Liabilities 67.3439 66.4893 61.1075 61.288 60.969
Equity 12.47 12.47 12.47 12.47 12.4699
Gross Profit -0.1174 4.8402 -0.2965 -0.5759 0
Net Profit 0.5551 3.8882 0.1465 -0.038 -0.1107
Cash From Operating Activities 1.8544 3.0939 -2.5962 -0.9508 2.2353
NPM(%) 22.97 54.26 144.47 0 0
Revenue 2.4166 7.1654 0.1014 0 0
Expenses 2.534 2.3252 0.3979 0.5759 0
ROE(%) 0.44 3.14 0.11 -0.03 -0.08

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0 10 0 14.5

Peers

Other companies within the same industry or sector that are comparable to MediCaps Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 804.00 0.49 72.87 22.47 301.39 0.62
Lotus Eye Hospital and Institute Ltd 123.95 -4.58 391.58 81.90 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 21.70 -1.23 0.00 170.04 -39.50 0.00
Astec Lifesciences Ltd 854.05 -0.85 0.00 77.23 -604.77 0.00

Company Info

The Company was incorporated on 6th August, 1983 as a Private Limited Company and was converted into Public Limited on 3rd March, 1986. The Company is engaged in manufacture of Empty Hard Gelatine Capsule. PRESENT BUSINESS The Company commenced manufacturing in June 1986 by installing Two Automatic Capsule Making Machine having installed capacity of 500 Million Capsules per annum. After initial consolidation the Company added the third machine in 1991 and fourth machine in 1992. The Company continued its expansion programme and added two more automatic machines in 1993-94 through internal accruals increasing the installed capacity to 1500 Million Capsules per annum. The Company is in process of acquiring its seventh automatic machine which is to be operational by Dec.,94 and the eighth machine is expected to be operational before March,95. By end of the current financial year the company will have eight automatic capsules making machine having installed capacity of 2000 Million Capsules per annum. 2005 -Medi Caps recommended dividend @ 15% 2006 -Medi Caps recommended dividend @ 15% 2007 -Medi Caps recommended dividend @ 15% 2008 -Medi Caps designed E-mail ID for Investors Complaints: investors@medicaps.com 2011 -Medi Caps recommended dividend @ 15% 2012 -Medi Caps recommended dividend @ 15% 2013 -Medi-Caps has given the Bonus in the Ratio of 3:1

The Company was incorporated on 6th August, 1983 as a Private Limited Company and was converted into Public Limited on 3rd March, 1986. The Company is engaged in manufacture of Empty Hard Gelatine Capsule. PRESENT BUSINESS The Company commenced manufacturing in June 1986 by installing Two Automatic Capsule Making Machine having installed capacity of 500 Million Capsules per annum. After initial consolidation the Company added the third machine in 1991 and fourth machine in 1992. The Company continued its expansion programme and added two more automatic machines in 1993-94 through internal accruals increasing the installed capacity to 1500 Million Capsules per annum. The Company is in process of acquiring its seventh automatic machine which is to be operational by Dec.,94 and the eighth machine is expected to be operational before March,95. By end of the current financial year the company will have eight automatic capsules making machine having installed capacity of 2000 Million Capsules per annum. 2005 -Medi Caps recommended dividend @ 15% 2006 -Medi Caps recommended dividend @ 15% 2007 -Medi Caps recommended dividend @ 15% 2008 -Medi Caps designed E-mail ID for Investors Complaints: investors@medicaps.com 2011 -Medi Caps recommended dividend @ 15% 2012 -Medi Caps recommended dividend @ 15% 2013 -Medi-Caps has given the Bonus in the Ratio of 3:1

Read More

Parent Organisation

MediCaps Ltd.

Founded

06/08/1983

Managing Director

Mr.Alok K Garg

NSE Symbol

MEDICAPSBE

FAQ

The current price of MediCaps Ltd is

The 52-week high for MediCaps Ltd is

The market capitalization of MediCaps Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy MediCaps Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in MediCaps Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase MediCaps Ltd shares.

The CEO of MediCaps Ltd is Mr.Alok K Garg, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT